Cargando…
151. Simplifying Empiric Antimicrobial Therapy Selection for Lower Respiratory Tract Infections in Intensive Care Unit Patients: Using Resistance Frequency to Guide Decision Making
BACKGROUND: In the US, the burden of multidrug resistant bacterial infections, including carbapenem-resistant P. aeruginosa (CRPA) and ESBL-producing Enterobacterales (ESBL-E), is substantial. These resistant pathogens may affect the delivery of timely effective therapy. The aim of this study is to...
Autores principales: | Klinker, Kenneth, Hidayat, Levita K, Andrew DeRyke, C, Motyl, Mary, Bauer, Karri A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644299/ http://dx.doi.org/10.1093/ofid/ofab466.151 |
Ejemplares similares
-
127. Living on the Edge: The Impact of MIC Distributions on Empiric Antibiotic Selection
por: Bauer, Karri A, et al.
Publicado: (2021) -
103. Empiric Antibiotic Susceptibility Using a Traditional vs. Syndromic Antibiogram-Implications for Antimicrobial Stewardship Programs
por: Klinker, Kenneth, et al.
Publicado: (2020) -
Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiograms
por: Klinker, Kenneth P., et al.
Publicado: (2021) -
Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States
por: Klinker, Kenneth P., et al.
Publicado: (2022) -
1450. Frequency of Carbapenem-resistant Pseudomonas aeruginosa Among Respiratory Pathogens Impacts First-Line Beta-Lactam Susceptibility: Potential Role for Ceftolozane/Tazobactam (C/T) and/or Imipenem/Relebactam (I/R)
por: Klinker, Kenneth, et al.
Publicado: (2020)